The Recall Desk
HighFDA (Devices)·Z-2071-2018·Announced 2018-06-13

Tosoh ST-AIA PACK CK-MB Recalled Due to Strensiq Interference

Tosoh Bioscience is recalling ST-AIA PACK CK-MB assays because Asfotase Alfa (Strensiq) interferes with the test, potentially causing inaccurate results.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves potential diagnostic errors (falsely increased or decreased results) which poses a risk of harm to patients, though no specific injuries or illnesses are reported in the source text.

Plain-English summary

Tosoh Bioscience Inc is recalling ST-AIA PACK CK-MB assays (Part Number: 025269). The recall affects 2,549 units distributed worldwide, including the United States, Canada, Mexico, and various countries in South and Central America.

The recall was initiated because Asfotase Alfa (Strensiq) interferes with certain Tosoh assays. This interference can potentially cause falsely increased or falsely decreased immunoassay test results, depending on the specific assay used.

Healthcare providers and laboratories should stop using the affected ST-AIA PACK CK-MB assays and contact Tosoh Bioscience for further instructions regarding the return or replacement of the product.

The recalled product

Product
ST-AIA PACK CK-MB; Part Number: 025269 Assay, Cardiac Marker
Affected units
2,549

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All Lot Codes

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 35 recalled by Tosoh Bioscience Inc under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 35 products in this recall →